![Michael Jung](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Jung
Oprichter bij
Enlibrium, Inc.
Profiel
Michael Jung is the founder of Aragon Pharmaceuticals, Inc. (founded in 2009) and Seragon Pharmaceuticals, Inc. (founded in 2013).
He is also the founder of Enlibrium, Inc. Dr. Jung's current job is as a Professor at the University of California, Berkeley.
Actieve functies van Michael Jung
| Bedrijven | Functie | Begin |
|---|---|---|
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 07-04-2010 |
Enlibrium, Inc.
 Enlibrium, Inc. Medical/Nursing ServicesHealth Services Provides medical services | Oprichter | - |
Eerdere bekende functies van Michael Jung
| Bedrijven | Functie | Einde |
|---|---|---|
Seragon Pharmaceuticals, Inc.
 Seragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products for the treatment of estrogen receptor dependent breast cancer | Oprichter | - |
Aragon Pharmaceuticals, Inc.
 Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Oprichter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
99
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aragon Pharmaceuticals, Inc.
Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Seragon Pharmaceuticals, Inc.
Seragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products for the treatment of estrogen receptor dependent breast cancer | Health Technology |
Enlibrium, Inc.
Enlibrium, Inc. Medical/Nursing ServicesHealth Services Provides medical services | Health Services |
